Muthumani, M <br/><br/>
Silibinin potentially attenuates arsenic-induced oxidative stress mediated cardiotoxicity and dyslipidemia in rats.  [electronic resource] 

 -  Cardiovascular toxicology  Mar 2014 
 - 83-97 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1559-0259 
<br/><br/><label>Standard No.: </label>10.1007/s12012-013-9227-x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenosine Triphosphatases--metabolism<br/>Animals<br/>Antioxidants--pharmacology<br/>Arsenites<br/>Disease Models, Animal<br/>Dyslipidemias--blood<br/>Heart Diseases--blood<br/>Heme Oxygenase (Decyclizing)--metabolism<br/>Intracellular Signaling Peptides and Proteins--metabolism<br/>Kelch-Like ECH-Associated Protein 1<br/>Lipids--blood<br/>Mitochondria, Heart--drug effects<br/>Myocardium--metabolism<br/>NADPH Oxidases--metabolism<br/>NF-E2-Related Factor 2--metabolism<br/>Oxidative Stress--drug effects<br/>Rats<br/>Silybin<br/>Silymarin--pharmacology<br/>Sodium Compounds